Star Equity Holdings, Inc. (STRR)
USD 2.36
(-2.88%)
USD 2.36
(-2.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.54 Million USD | 70.53% |
| 2022 | -5.25 Million USD | 41.19% |
| 2021 | -8.93 Million USD | -68.99% |
| 2020 | -5.28 Million USD | -8.01% |
| 2019 | -4.89 Million USD | -764.81% |
| 2018 | 736 Thousand USD | 102.06% |
| 2017 | -35.73 Million USD | -349.83% |
| 2016 | 14.3 Million USD | -33.91% |
| 2015 | 21.64 Million USD | 774.34% |
| 2014 | 2.47 Million USD | 837.5% |
| 2013 | 264 Thousand USD | 105.36% |
| 2012 | -4.92 Million USD | -47.34% |
| 2011 | -3.34 Million USD | 46.22% |
| 2010 | -6.21 Million USD | -1122.04% |
| 2009 | 608 Thousand USD | 108.86% |
| 2008 | -6.86 Million USD | -398.91% |
| 2007 | -1.37 Million USD | 78.12% |
| 2006 | -6.29 Million USD | 34.61% |
| 2005 | -9.61 Million USD | -4026.12% |
| 2004 | 245 Thousand USD | 114.58% |
| 2003 | -1.68 Million USD | 86.84% |
| 2002 | -12.77 Million USD | 35.86% |
| 2001 | -19.91 Million USD | -47.75% |
| 2000 | -13.47 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.22 Million USD | -228.7% |
| 2024 Q2 | -3.78 Million USD | -70.28% |
| 2023 Q4 | 1.72 Million USD | 165.9% |
| 2023 Q3 | -2.62 Million USD | -110.25% |
| 2023 FY | -1.54 Million USD | 70.53% |
| 2023 Q1 | -55 Thousand USD | -102.88% |
| 2023 Q2 | 25.59 Million USD | 46629.09% |
| 2022 FY | -5.25 Million USD | 41.19% |
| 2022 Q1 | -3.7 Million USD | 16.23% |
| 2022 Q2 | -2.05 Million USD | 44.47% |
| 2022 Q3 | -1.88 Million USD | 8.32% |
| 2022 Q4 | 1.9 Million USD | 201.33% |
| 2021 Q3 | -2.14 Million USD | -15.36% |
| 2021 Q2 | -1.85 Million USD | -137.47% |
| 2021 FY | -8.93 Million USD | -68.99% |
| 2021 Q1 | 4.95 Million USD | 1186.18% |
| 2021 Q4 | -4.41 Million USD | -106.35% |
| 2020 FY | -5.28 Million USD | -8.01% |
| 2020 Q2 | -1.28 Million USD | 56.42% |
| 2020 Q3 | -1.76 Million USD | -36.75% |
| 2020 Q4 | -456 Thousand USD | 74.09% |
| 2020 Q1 | -2.95 Million USD | -1049.03% |
| 2019 FY | -4.89 Million USD | -764.81% |
| 2019 Q4 | -257 Thousand USD | 82.91% |
| 2019 Q1 | -1.65 Million USD | -3.95% |
| 2019 Q2 | -1.2 Million USD | 27.04% |
| 2019 Q3 | -1.5 Million USD | -24.4% |
| 2018 Q4 | -1.59 Million USD | -11.78% |
| 2018 Q3 | -1.42 Million USD | -307.43% |
| 2018 FY | 736 Thousand USD | 102.06% |
| 2018 Q1 | 4.1 Million USD | 118.68% |
| 2018 Q2 | -350 Thousand USD | -108.52% |
| 2017 Q1 | -2.07 Million USD | -204.95% |
| 2017 FY | -35.73 Million USD | -349.83% |
| 2017 Q4 | -21.98 Million USD | -147.03% |
| 2017 Q3 | -8.89 Million USD | -221.03% |
| 2017 Q2 | -2.77 Million USD | -33.53% |
| 2016 Q1 | 11.6 Million USD | 1612.24% |
| 2016 Q4 | 1.97 Million USD | 798.94% |
| 2016 Q3 | -283 Thousand USD | -128.36% |
| 2016 FY | 14.3 Million USD | -33.91% |
| 2016 Q2 | 998 Thousand USD | -91.4% |
| 2015 Q2 | 1.09 Million USD | 47.25% |
| 2015 FY | 21.64 Million USD | 774.34% |
| 2015 Q4 | 678 Thousand USD | -96.45% |
| 2015 Q1 | 745 Thousand USD | -3.5% |
| 2015 Q3 | 19.12 Million USD | 1642.94% |
| 2014 Q1 | -148 Thousand USD | -118.81% |
| 2014 Q2 | 823 Thousand USD | 656.08% |
| 2014 FY | 2.47 Million USD | 837.5% |
| 2014 Q4 | 772 Thousand USD | -24.9% |
| 2014 Q3 | 1.02 Million USD | 24.91% |
| 2013 Q2 | -616 Thousand USD | 74.53% |
| 2013 FY | 264 Thousand USD | 105.36% |
| 2013 Q4 | 787 Thousand USD | -68.67% |
| 2013 Q3 | 2.51 Million USD | 507.79% |
| 2013 Q1 | -2.41 Million USD | -30.12% |
| 2012 FY | -4.92 Million USD | -47.34% |
| 2012 Q3 | -906 Thousand USD | -1.68% |
| 2012 Q2 | -891 Thousand USD | 29.73% |
| 2012 Q1 | -1.26 Million USD | 55.15% |
| 2012 Q4 | -1.85 Million USD | -105.19% |
| 2011 Q1 | -387 Thousand USD | 30.77% |
| 2011 FY | -3.34 Million USD | 46.22% |
| 2011 Q4 | -2.82 Million USD | -2955.56% |
| 2011 Q3 | 99 Thousand USD | 143.42% |
| 2011 Q2 | -228 Thousand USD | 41.09% |
| 2010 FY | -6.21 Million USD | -1122.04% |
| 2010 Q1 | -1.23 Million USD | -736.6% |
| 2010 Q4 | -559 Thousand USD | 58.16% |
| 2010 Q3 | -1.33 Million USD | 56.68% |
| 2010 Q2 | -3.08 Million USD | -149.72% |
| 2009 FY | 608 Thousand USD | 108.86% |
| 2009 Q2 | 784 Thousand USD | 1681.82% |
| 2009 Q3 | -414 Thousand USD | -152.81% |
| 2009 Q1 | 44 Thousand USD | 101.28% |
| 2009 Q4 | 194 Thousand USD | 146.86% |
| 2008 Q1 | -1.39 Million USD | -26.82% |
| 2008 Q2 | -1.15 Million USD | 17.13% |
| 2008 Q3 | -869 Thousand USD | 24.83% |
| 2008 Q4 | -3.44 Million USD | -296.43% |
| 2008 FY | -6.86 Million USD | -398.91% |
| 2007 Q4 | -1.1 Million USD | -87.07% |
| 2007 Q1 | 74 Thousand USD | 149.66% |
| 2007 Q2 | 238 Thousand USD | 221.62% |
| 2007 FY | -1.37 Million USD | 78.12% |
| 2007 Q3 | -588 Thousand USD | -347.06% |
| 2006 Q2 | -1.2 Million USD | 57.1% |
| 2006 Q3 | -2.13 Million USD | -77.39% |
| 2006 FY | -6.29 Million USD | 34.61% |
| 2006 Q1 | -2.8 Million USD | -1.23% |
| 2006 Q4 | -149 Thousand USD | 93.02% |
| 2005 Q3 | -2.82 Million USD | 7.04% |
| 2005 Q4 | -2.77 Million USD | 2.02% |
| 2005 FY | -9.61 Million USD | -4026.12% |
| 2005 Q1 | -981 Thousand USD | -4537.51% |
| 2005 Q2 | -3.04 Million USD | -209.99% |
| 2004 Q4 | 22.1 Thousand USD | -94.27% |
| 2004 Q2 | 102.64 Thousand USD | 138.65% |
| 2004 FY | 245 Thousand USD | 114.58% |
| 2004 Q3 | 386 Thousand USD | 276.06% |
| 2004 Q1 | -265.55 Thousand USD | 0.0% |
| 2003 Q2 | -795.3 Thousand USD | 14.19% |
| 2003 Q1 | -926.82 Thousand USD | 0.0% |
| 2003 FY | -1.68 Million USD | 86.84% |
| 2002 FY | -12.77 Million USD | 35.86% |
| 2001 FY | -19.91 Million USD | -47.75% |
| 2000 FY | -13.47 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 99.334% |
| Prenetics Global Limited | -62.72 Million USD | 97.532% |
| CareDx, Inc | -190.28 Million USD | 99.186% |
| Exact Sciences Corporation | -204.14 Million USD | 99.242% |
| Exagen Inc. | -23.68 Million USD | 93.465% |
| Inotiv, Inc. | -105.14 Million USD | 98.528% |
| Guardant Health, Inc. | -479.44 Million USD | 99.677% |
| Biodesix, Inc. | -52.14 Million USD | 97.031% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | 41.119% |
| Precipio, Inc. | -5.85 Million USD | 73.552% |
| iSpecimen Inc. | -11.09 Million USD | 86.053% |
| Natera, Inc. | -434.8 Million USD | 99.644% |
| Aspira Women's Health Inc. | -16.69 Million USD | 90.725% |
| Standard BioTools Inc. | -74.65 Million USD | 97.926% |
| 23andMe Holding Co. | -666.7 Million USD | 99.768% |
| Castle Biosciences, Inc. | -57.46 Million USD | 97.306% |
| Personalis, Inc. | -108.29 Million USD | 98.571% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 98.25% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | 84.438% |
| OpGen, Inc. | -32.66 Million USD | 95.261% |
| T2 Biosystems, Inc. | -50.07 Million USD | 96.909% |
| Myriad Genetics, Inc. | -112 Million USD | 98.618% |
| ICON Public Limited Company | 612.33 Million USD | 100.253% |
| NeoGenomics, Inc. | -87.96 Million USD | 98.24% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -0.0% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 100.183% |
| RadNet, Inc. | 3.04 Million USD | 150.854% |
| MDxHealth SA | -43.1 Million USD | 96.408% |
| Psychemedics Corporation | -4.15 Million USD | 62.735% |
| Illumina, Inc. | -1.16 Billion USD | 99.867% |
| Check-Cap Ltd. | -17.56 Million USD | 91.189% |
| Twist Bioscience Corporation | -208.72 Million USD | 99.258% |
| DarioHealth Corp. | -59.42 Million USD | 97.395% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 99.078% |
| Sera Prognostics, Inc. | -36.24 Million USD | 95.729% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | 84.613% |
| OPKO Health, Inc. | -188.86 Million USD | 99.18% |
| Medpace Holdings, Inc. | 282.81 Million USD | 100.547% |
| Neogen Corporation | -9.42 Million USD | 83.569% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | 84.759% |
| Prenetics Global Limited | -62.72 Million USD | 97.532% |
| Mainz Biomed B.V. | -26.29 Million USD | 94.113% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | 80.496% |
| Trinity Biotech plc | -24.01 Million USD | 93.555% |
| Neuronetics, Inc. | -30.18 Million USD | 94.872% |
| Sotera Health Company | 51.37 Million USD | 103.013% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | 80.496% |